0001567619-21-013567.txt : 20210716
0001567619-21-013567.hdr.sgml : 20210716
20210716160221
ACCESSION NUMBER: 0001567619-21-013567
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210714
FILED AS OF DATE: 20210716
DATE AS OF CHANGE: 20210716
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENNEY CHRISTOPHER S
CENTRAL INDEX KEY: 0001242880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35676
FILM NUMBER: 211095491
MAIL ADDRESS:
STREET 1: 10505 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTHENA CORP PUBLIC LTD CO
CENTRAL INDEX KEY: 0001559053
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 77 SIR JOHN ROGERSON'S QUAY, BLOCK C
STREET 2: GRAND CANAL DOCKLANDS
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
BUSINESS PHONE: 011-353-1-236-2500
MAIL ADDRESS:
STREET 1: 77 SIR JOHN ROGERSON'S QUAY, BLOCK C
STREET 2: GRAND CANAL DOCKLANDS
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
FORMER COMPANY:
FORMER CONFORMED NAME: Prothena Corp plc
DATE OF NAME CHANGE: 20121102
FORMER COMPANY:
FORMER CONFORMED NAME: Neotope Corp Ltd
DATE OF NAME CHANGE: 20120926
4
1
doc1.xml
FORM 4
X0306
4
2021-07-14
0
0001559053
PROTHENA CORP PUBLIC LTD CO
PRTA
0001242880
HENNEY CHRISTOPHER S
C/O PROTHENA BIOSCIENCES INC
331 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Ordinary Shares, par value $0.01 per share
2021-07-14
4
M
0
11108
11.33
A
11108
D
Ordinary Shares, par value $0.01 per share
2021-07-14
4
S
0
9108
55.3093
D
2000
D
Ordinary Shares, par value $0.01 per share
2021-07-14
4
S
0
2000
56.1315
D
0
D
Stock Option (Right to Buy)
11.33
2021-07-14
4
M
0
11108
0
D
2030-05-20
Ordinary Shares
11108
0
D
The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The transaction was executed in multiple trades in prices ranging from $55.00 to $55.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The transaction was executed in multiple trades in prices ranging from $56.005 to $56.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The shares subject to the option were fully vested as of the date of the exercise.
/s/ Karin L. Walker, as Attorney in Fact for Christopher Henney
2021-07-16